Company intelligence / Profile preview

Medical Wireless Sensing

London, United Kingdom

Ownership: Private
Development stage: Other

Overview

Pre-clinical research and development stage. Notable achievements include first in vivo glucose monitoring animal study in pigs correlating radio frequency signal transmission changes with blood glucose concentration in the 58-62 GHz frequency range[3]. Research demonstrating metamaterial enhancement of microwave brain imaging for hemorrhage detection[3]. Development of non-invasive glucose monitoring system (Glucowise) and microwave brain imaging applications[2].

Therapeutic areas: OncologyEndocrinologyNeurology
Modalities: DeviceWireless medical devices
Industry: Physiological Monitoring

Partnerships

Queen Mary University (London, England)King's College (London, England)Leiden University Medical Centre (Netherlands)

Beyond the preview

Go deeper on Medical Wireless Sensing.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medical Wireless Sensing.

Explore the full profile